Industries > Pharma > Global Translational Regenerative Medicine Market Prospects 2017-2027

Global Translational Regenerative Medicine Market Prospects 2017-2027

Stem Cell Therapies, Tissue Engineered Products, Gene Therapies

PUBLISHED: 05 April 2017
PAGES: 316
PRODUCT CODE: PHA0183

Clear
WOOCS 2.2.1
SKU: PHA0183 Categories: , ,

The translational regenerative medicine market has been undergoing considerable changes over the last few years. There are a number of therapies that have been launched into the market over the last few years. Stem cell therapies are being developed constantly and these are targeted at various indications, from the more common cardiovascular conditions to rarer orphan indications.

The Global Translational Regenerative Medicine market is expected to grow significantly over the forecast period. The Global Translational Regenerative Medicine market was valued at $5.8bn in 2016. Visiongain forecasts this market to increase to $14.5bn in 2021. The market is estimated to grow at a CAGR of 19.9% in the first half of the forecast period and 17.7% from 2016 to 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 316-page report you will receive 107 tables and 66 figures – all unavailable elsewhere.

The 316-page report provides clear detailed insight into the Global Translational Regenerative Medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Translational Regenerative Medicine Market Prospects 2017-2027

Report Scope
Global Translational Regenerative Medicine market forecasts from 2017-2027

• Translational Regenerative Medicine regional market forecasts from 2017-2027, covering:
– United States
– Europe
– Asia-Pacific
– Rest of the World

• Global Translational Regenerative Medicine submarket forecasts from 2017-2027 covering:
– Stem Cell Therapies
– Tissue Engineered Products
– Gene Therapies

• Forecasts from 2017-2027 of the leading products in the Global Translational Regenerative Medicine market:
– Osteocel Plus
– Trinity ELITE
– TEMCELL /Prochymal
– Apligraf
– Dermagraft
– Epifix
– ReCell
– Neovasculgen
– Glybera (alipogene tiparvovec)
– IMLYGIC (talimogene laherparepvec)

• Assessment of the leading companies in the Global Translational Regenerative Medicine market:
– Alphatec Spine
– Anterogen
– Athersys
– Avita Medical
– AxoGen
– Medipost
– Mesoblast
– NuVasive
– Ocata Therapeutics
– Organogenesis
– Osiris Therapeutics
– Pharmicell
– Regenerys
– TiGenix
– UniQure
– Vericel Corporation

SWOT and Porter’s Five Force analysis of the translational regenerative medicine market

Visiongain’s study is intended for anyone requiring commercial analyses for the Translational Regenerative Medicine Market and leading companies. You find data, trends and predictions.

Buy our report today Global Translational Regenerative Medicine Market Prospects 2017-2027: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Translational Regenerative Medicine Market Prospects 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Translational Regenerative Medicine Market Prospects 2017-2027


Latest Pharma news

Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030

Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

19 October 2020

READ

Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.

12 October 2020

READ

Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030

We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

02 October 2020

READ

Visiongain Publishes mRNA Vaccines Market Report 2021-2031

The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.

02 October 2020

READ

Categories

Category